AUTHOR=Wang Wei , Guo Xiu Li , Qiu Xiu Ping , Yu Yun Jie , Tu Mei 

TITLE=Systemic immune-inflammation index mediates the association between metabolic dysfunction-associated fatty liver disease and sub-clinical carotid atherosclerosis: a mediation analysis

JOURNAL=Frontiers in Endocrinology

VOLUME=15

YEAR=2024

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1406793

DOI=10.3389/fendo.2024.1406793

ISSN=1664-2392

ABSTRACT=<sec><title>Background</title><p>Limited research has been conducted to quantitatively assess the impact of systemic inflammation in metabolic dysfunction-associated fatty liver disease (MAFLD) and sub-clinical carotid atherosclerosis (SCAS). The systemic immune-inflammation index (SII), which integrates inflammatory cells, has emerged as a reliable measure of local immune response and systemic inflammation Therefore, this study aims to assess the mediating role of SII in the association between MAFLD and SCAS in type 2 diabetes mellitus (T2DM).</p></sec><sec><title>Method</title><p>This study prospectively recruited 830 participants with T2DM from two centers. Unenhanced abdominal CT scans were conducted to evaluate MAFLD, while B-mode carotid ultrasonography was performed to assess SCAS. Weighted binomial logistic regression analysis and restricted cubic splines (RCS) analyses were employed to analyze the association between the SII and the risk of MAFLD and SCAS. Mediation analysis was further carried out to explore the potential mediating effect of the SII on the association between MAFLD and SCAS.</p></sec><sec><title>Results</title><p>The prevalence of both MAFLD and SCAS significantly increased as the SII quartiles increased (<italic>P&lt;</italic>0.05). MAFLD emerged as an independent factor for SCAS risk across three adjusted models, exhibiting odds ratios of 2.15 (95%CI: 1.31–3.53, <italic>P</italic> &lt; 0.001). Additionally, increased SII quartiles and Ln (SII) displayed positive associations with the risk of MAFLD and SCAS (<italic>P</italic> &lt; 0.05). Furthermore, a significant dose-response relationship was observed (<italic>P</italic> for trend &lt;0.001). The RCS analyses revealed a linear correlation of Ln (SII) with SCAS and MAFLD risk (<italic>P</italic> for nonlinearity<italic>&lt;</italic>0.05). Importantly, SII and ln (SII) acted as the mediators in the association between MAFLD and SCAS following adjustments for shared risk factors, demonstrating a proportion-mediated effect of 7.8% and 10.9%.</p></sec><sec><title>Conclusion</title><p>SII was independently correlated with MAFLD and SCAS risk, while also acting as a mediator in the relationship between MAFLD and SCAS.</p></sec>